Top compounds associated with response to ZNF347


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.003
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.11 0.004
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.099 0.004
mRNA brivanib CTRPv2 pan-cancer AAC -0.11 0.004
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.11 0.004
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.09 0.004
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.005
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.11 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.12 0.005
Download CSV